AGP Picks
View all

Koate-DVI market to grow on bleeding disorders, aging populations

Nov. 5, 2026
Koate-DVI market to grow on bleeding disorders, aging populations
By AI, Created 15:15 UTC, Nov 05, 2026, AGP -

The Business Research Company says the Koate-DVI market is expanding on rising bleeding disorder diagnoses, higher healthcare spending and aging populations. North America leads now, while Asia-Pacific is expected to post the fastest growth through the forecast period.

Why it matters: - Koate-DVI demand is tied to treatment for bleeding disorders, including hemophilia A, so market growth tracks a real therapeutic need. - Expanding patient counts, higher healthcare spending and broader access to care can lift use of specialized factor replacement therapies. - The report frames Koate-DVI as part of a wider shift toward delayed-release and protective pharmaceutical technologies.

What happened: - The Business Research Company released its Koate-DVI Global Market Report 2026, covering market size, trends and a forecast through 2035. - The report says North America is the largest regional market for Koate-DVI as of 2025. - The report says Asia-Pacific is the fastest-growing region in the forecast period. - The analysis also covers Western Europe, Eastern Europe, South America, the Middle East and Africa.

The details: - Koate-DVI is described as a pharmaceutical coating polymer used mainly for delayed-release oral medicines. - The coating is designed to protect active ingredients from stomach acid and release the drug after it passes into the intestine. - The report says Koate-DVI coatings help protect drugs from moisture, heat and light. - Market growth in recent years was supported by the need to shield active pharmaceutical ingredients in oral solid dosage forms. - Other growth drivers included early development of enteric coating polymers, higher use of medicines for chronic diseases and expanded pharmaceutical manufacturing capacity. - The report expects growth to be supported by patient-friendly oral medicines, modified-release formulations, generic drug production, coating polymer innovation and demand for better drug stability. - The report flags delayed-release oral formulations, protective polymer coatings, targeted drug delivery systems and coatings resistant to moisture and stomach acid as key trends. - Controlled-release pharmaceuticals are becoming more widely adopted, according to the report. - The report links market growth to the increasing prevalence of bleeding disorders worldwide. - Better awareness, genetic predisposition, lifestyle changes and improved screening are driving more diagnoses. - Koate-DVI is used in managing hemophilia A by replacing missing clotting factors such as factor VIII. - By the end of 2024, the World Bleeding Disorders Registry showed an 18.5% increase in registered patients from the prior year. - Healthcare spending is also supporting demand as governments and health systems spend more on services, pharmaceuticals and infrastructure. - The report points to the UK, where health expenditure rose 5.6% nominally from 2022 to 2023. - Aging populations are another tailwind because bleeding complications can become more serious with age. - The Population Reference Bureau projects Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, a 47% increase.

Between the lines: - The market story is less about a single product and more about a broader increase in chronic disease management, specialty drug delivery and pharmaceutical manufacturing capacity. - North America’s lead likely reflects stronger healthcare infrastructure and higher awareness, while Asia-Pacific’s growth points to expanding access and local production. - The report’s focus on coating performance suggests competitive pressure is shifting toward durability, stability and release control rather than basic formulation alone.

What's next: - The Business Research Company expects continued growth in delayed-release, moisture-resistant and stomach-acid-resistant coating technologies. - Generic drug production and modified-release formulations are likely to remain important demand drivers through 2035. - The company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspot infographics, and key technology and future trend analysis. - Download a free sample of the Koate-DVI market report - View the full Koate-DVI market report

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

UK Post Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

UK Post Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.